Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors
Abstract Background The discovery of epidermal growth factor receptor (EGFR) inhibitors for the treatment of lung cancer, most especially non-small cell lung cancer (NSCLC), was one of the major challenges encountered by the medicinal chemist in the world. The treatment of EGFR tyrosine kinase to ma...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-11-01
|
Series: | Egyptian Journal of Medical Human Genetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43042-020-00107-y |